Orna Therapeutics

Orna Therapeutics is a biotechnology company based in Watertown, Massachusetts, founded in 2019. The company specializes in developing circular RNA (oRNA) therapeutics using its proprietary engineering and delivery platforms. Orna focuses on creating next-generation RNA-based medicines aimed at treating diseases in oncology, autoimmune disorders, and genetic conditions. The core innovation of Orna is its oRNA® technology, which produces circular RNA molecules through self-circularization of linear RNA. This method enhances stability, prolongs protein expression, and reduces immunogenicity. Orna's pipeline includes targets such as B-cell malignancies, autoimmune diseases, sickle cell disease, and β-thalassemia. The company has established strategic collaborations, including a partnership with Merck to advance oRNA technology and an acquisition of ReNAgade Therapeutics to enhance its delivery capabilities. With secured Series B funding and multiple patents, Orna Therapeutics is positioned to lead in the field of RNA-based medicine.

Research Watertown, United States ~170 employees Private · Series B

Work at Orna Therapeutics in HR or recruiting? Claim this page

Employees
170
Revenue / employee
$226K
Revenue ~$38.5M
Total funding
$321M
Last round Series B, Aug 2022
H1B filings, FY2026
2
Sponsors visas

Funding rounds

Total funding$321M
Funding rounds3
Investors7
DateRoundMoney raisedNo.Investors
Aug 2022Series B$221M2
Feb 2021Series A$80M6
Oct 2019Funding$20M––

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering9
Operations3

The department split adds up all the years listed above. FY2026 alone: 2 filings.

Peer reviews

Worked with someone at Orna Therapeutics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Orna Therapeutics FAQ

How many employees does Orna Therapeutics have?

Orna Therapeutics has about 170 employees (as of Nov 2026).

Does Orna Therapeutics sponsor H1B visas?

Yes. Orna Therapeutics filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Orna Therapeutics's revenue per employee?

Orna Therapeutics makes about $226K in revenue per employee, based on $38.5M annual revenue and 170 employees.

How much funding has Orna Therapeutics raised?

Orna Therapeutics has raised $321M in total funding; its latest round was Series B in Aug 2022.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.